Video: ATOM Consortium to Accelerate AI in Drug Discovery with NVIDIA

The Public-private consortium ATOM has announced today that it is collaborating with NVIDIA to scale ATOM's AI-driven drug discovery platform. "Scientists at ATOM have created a predictive model development pipeline that calls upon large datasets to build and test predictive machine learning models which consider pharmacokinetics, safety, developability, and efficacy. NVIDIA will provide additional resources that will enable this pipeline to be run at increased scale and speed."

The post Video: ATOM Consortium to Accelerate AI in Drug Discovery with NVIDIA appeared first on insideHPC.